Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial

Markus Ketteler; Andrzej Wiecek; Alexander R. Rosenkranz; Andreas Pasch; Jan Rekowski; Burkhard Hellmann; Michael Karus; Richard Ammer

doi:10.1016/j.ekir.2020.12.012

Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial

Markus Ketteler
, Andrzej Wiecek
, Alexander R. Rosenkranz
, Andreas Pasch
, Jan Rekowski
, Burkhard Hellmann
, Michael Karus
, Richard Ammer

Department of Physiology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	594-604
Number of pages	11
Journal	Kidney International Reports
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/j.ekir.2020.12.012
Publication status	Published - Mar 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

301110 Physiology

Access to Document

10.1016/j.ekir.2020.12.012

Cite this

Ketteler, M., Wiecek, A., Rosenkranz, A. R., Pasch, A., Rekowski, J., Hellmann, B., Karus, M., & Ammer, R. (2021). Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial. Kidney International Reports, 6(3), 594-604. https://doi.org/10.1016/j.ekir.2020.12.012

@article{9d7895769fff4d5a88e3bc288baf7b8f,

title = "Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial",

author = "Markus Ketteler and Andrzej Wiecek and Rosenkranz, \{Alexander R.\} and Andreas Pasch and Jan Rekowski and Burkhard Hellmann and Michael Karus and Richard Ammer",

year = "2021",

month = mar,

doi = "10.1016/j.ekir.2020.12.012",

language = "English",

volume = "6",

pages = "594--604",

journal = "Kidney International Reports",

issn = "2468-0249",

number = "3",

}

Ketteler, M, Wiecek, A, Rosenkranz, AR, Pasch, A, Rekowski, J, Hellmann, B, Karus, M & Ammer, R 2021, 'Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial', Kidney International Reports, vol. 6, no. 3, pp. 594-604. https://doi.org/10.1016/j.ekir.2020.12.012

Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial. / Ketteler, Markus; Wiecek, Andrzej; Rosenkranz, Alexander R. et al.
In: Kidney International Reports, Vol. 6, No. 3, 03.2021, p. 594-604.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial

AU - Ketteler, Markus

AU - Wiecek, Andrzej

AU - Rosenkranz, Alexander R.

AU - Pasch, Andreas

AU - Rekowski, Jan

AU - Hellmann, Burkhard

AU - Karus, Michael

AU - Ammer, Richard

PY - 2021/3

Y1 - 2021/3

UR - https://www.scopus.com/pages/publications/85101022326

U2 - 10.1016/j.ekir.2020.12.012

DO - 10.1016/j.ekir.2020.12.012

M3 - Article

C2 - 33732974

SN - 2468-0249

VL - 6

SP - 594

EP - 604

JO - Kidney International Reports

JF - Kidney International Reports

IS - 3

ER -

Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this